Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00471978 · ClinicalTrials.gov registry record
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
A clinical trial of Lung Cancer, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 2
- Study locations
NCT00471978: Recruiting study of Lung Cancer, sponsored by Massachusetts General Hospital.
NCT00471978 is a study of Lung Cancer that is actively recruiting participants, run by Massachusetts General Hospital. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00471978, a study of Lung Cancer, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 2
- Study locations
Study Summary
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
Conditions Studied
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Harvard School of Public Health - Boston
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-09 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00471978
The ClinicalTrials.gov registry entry for NCT00471978 describes a study currently listed as recruiting, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00471978 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00471978 about?
NCT00471978 is a clinical study titled "DNA Analysis of Blood and Tissue from Patients with Lung Cancer". RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in...
What is the current status of trial NCT00471978?
This trial is currently recruiting. The study started on 2005-09. Estimated completion is 2026-09.
What conditions does trial NCT00471978 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT00471978?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00471978 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.